What is she best known for?
The fields of study she is best known for:
- Dopamine
- Neurotransmitter
- Neuron
Michele Morari mostly deals with Glutamate receptor, Dopamine, Endocrinology, Internal medicine and Neuroscience.
The various areas that Michele Morari examines in her Glutamate receptor study include Pharmacology, Neurotransmitter and Abnormal involuntary movement.
Her studies deal with areas such as -Naloxone and Antagonist as well as Pharmacology.
Her Endocrinology research includes elements of NMDA receptor and Dyskinesia.
The study incorporates disciplines such as Nociceptin receptor and Parkinson's disease in addition to Neuroscience.
Her Nociceptin receptor research is multidisciplinary, incorporating elements of Opioid receptor and Receptor antagonist.
Her most cited work include:
- Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. (244 citations)
- Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease. (182 citations)
- [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor. (155 citations)
What are the main themes of her work throughout her whole career to date?
Her scientific interests lie mostly in Internal medicine, Endocrinology, Glutamate receptor, Pharmacology and Dopamine.
Her study explores the link between Endocrinology and topics such as Biochemistry that cross with problems in Biophysics.
Her research in Glutamate receptor intersects with topics in Striatum, Raclopride, Neurotransmitter, Substantia nigra and Microdialysis.
Her biological study spans a wide range of topics, including Nociceptin receptor, Agonist, Receptor, NOP and Dyskinesia.
Michele Morari studied Dopamine and Parkinson's disease that intersect with Cell biology.
Her Neuroscience research integrates issues from Neurodegeneration and Disease.
She most often published in these fields:
- Internal medicine (39.20%)
- Endocrinology (39.20%)
- Glutamate receptor (35.20%)
What were the highlights of her more recent work (between 2017-2021)?
- Substantia nigra (25.60%)
- Cell biology (11.20%)
- Parkinson's disease (18.40%)
In recent papers she was focusing on the following fields of study:
Her main research concerns Substantia nigra, Cell biology, Parkinson's disease, Neuroscience and LRRK2.
The concepts of her Substantia nigra study are interwoven with issues in Glutamate receptor and Basal ganglia.
In Basal ganglia, Michele Morari works on issues like Striatum, which are connected to NOP and Nociceptin receptor.
Her Parkinson's disease study frequently draws parallels with other fields, such as Dopamine.
Endocrinology and Internal medicine are the areas that her Dopamine study falls under.
Her research investigates the link between Neuroscience and topics such as Neurodegeneration that cross with problems in Translocator protein and Preclinical imaging.
Between 2017 and 2021, her most popular works were:
- G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged mice (28 citations)
- Autophagy and LRRK2 in the Aging Brain (19 citations)
- Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease (18 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
